NCT07662928

Epcoritamab in Combination With Dose Adjusted EPOCH-R for High-risk Burkitt Lymphoma (BL), The BEDROCK Study

RecruitingPHASE2INTERVENTIONAL

Trial Details

Start: 2026-09-17Est. Completion: 2031-05-30

Enrollment target: 43 participants

Locations

B Acute Lymphoblastic Leukemia

This pilot trial assesses the effect of the combination of blinatumomab with dasatinib or imatinib and standard chemothe…

Birmingham, United StatesEst. completion Dec 1, 2030

Adult Burkitt LymphomaChemotherapy-Related ToxicityOverall and Progression-Free Survival

Burkitt lymphoma is a rare, highly aggressive B-cell non-Hodgkin lymphoma in adults. Although intensive multi-agent chem…

Strasbourg, FranceEst. completion Feb 11, 2027

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.